COMMUNIQUÉS West-GlobeNewswire

BioTelemetry, Inc. Elects Stephan Rietiker to its Board of Directors
07/11/2018
MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) announced today that Stephan Rietiker has been elected to BioTelemetry’s Board of Directors. Dr. Rietiker was most recently the Chief [...]
Neon Therapeutics Appoints Industry Veteran Robert Bazemore to its Board of Directors
07/11/2018
Seasoned executive brings more than 20 years of biopharmaceutical industry experience CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company [...]
Supernus to Present at Three November Healthcare Conferences
07/11/2018
ROCKVILLE, Md., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2018 Financial Results
07/11/2018
-Initiated Phase 1/2 Clinical Trial of CTX001 in β-thalassemia- -Targeting Initiation of Clinical Trial for CTX110, Targeting CD19+ Malignancies, in 1H 2019- -$487.3 Million in Cash as of September 30, 2018- ZUG, [...]
Verrica Pharmaceuticals Reports Third Quarter 2018 Financial Results
07/11/2018
WEST CHESTER, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical [...]
Geron to Present at Upcoming Investor Conferences in November
07/11/2018
MENLO PARK, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, is scheduled to present a company overview at [...]
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
07/11/2018
CRESTWOOD, Ky. and WALTHAM Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Retrophin to Present at the Jefferies 2018 London Healthcare Conference
07/11/2018
SAN DIEGO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Stephen Aselage, chief executive officer, will present at the Jefferies 2018 London Healthcare Conference in London, UK on [...]
University of Tübingen Names CureVac Co-Founder & Supervisory Board Chairman, Ingmar Hoerr, Honorary Senator
07/11/2018
TÜBINGEN, Germany and BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, congratulates CureVac co-founder and Chairman of the [...]
Zosano Pharma to Host Conference Call on Third Quarter 2018 Financial Results and Provide Operational Update
07/11/2018
FREMONT, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) (“Zosano” or the “Company”), a clinical-stage biopharmaceutical company, today announced that it will host a conference call and [...]
Clearside Biomedical to Participate in Stifel 2018 Healthcare Conference
07/11/2018
ALPHARETTA, Ga., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
MyoKardia Reports Third Quarter 2018 Financial Results
07/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today [...]
Sarepta Therapeutics Announces Proposed $500,000,000 Public Offering of Common Stock
07/11/2018
CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market and [...]
Catalyst Pharmaceuticals Announces Third Quarter 2018 Financial Results and Provides Corporate Update
07/11/2018
Company to Host Quarterly Conference Call at 8:30 am ET Tomorrow CORAL GABLES, Fla., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and [...]
Osiris Therapeutics, Inc Reports Third Quarter 2018 Results
07/11/2018
COLUMBIA, Md., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, [...]
Fluidigm Recognized as a Company to Watch in 2019
07/11/2018
Immuno-oncology innovator receives life science people’s choice award SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm serving the life science [...]
Inovalon Reports Third Quarter 2018 Results
07/11/2018
Third Quarter 2018 Highlights Q3 revenue of $145.8 million Q3 net loss of $0.8 million, resulting in net loss of $0.01 per share Q3 Non-GAAP net income of $16.3 million, resulting in Non-GAAP net income of $0.11 per [...]
Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinson’s Disease
07/11/2018
One-time treatment with VY-AADC demonstrates durable improvements in motor function at 18 months and beyond from ongoing Phase 1b trial CAMBRIDGE, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. ( [...]
Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights
07/11/2018
One-time treatment with VY-AADC demonstrates durable improvements in motor function at 18 months and beyond from ongoing Phase 1b trial Recent preclinical results for Huntington’s disease and Amyotrophic Lateral [...]

Pages